Concepedia

James Mulhearn

JM

14

Publications

369

Citations

13

H-Index

2005

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

James Mulhearn is an author at United States Military Academy specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2005–2024

14

Publications

14

Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT)

Scott T. Harrison, Michael S. Poslusney, James Mulhearn et al. · ACS Medicinal Chemistry Letters · 2015 · 44 citations · Full text

Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases

Ling Tong, Wenping Li, Michael Man‐Chu Lo et al. · Journal of Medicinal Chemistry · 2020 · 39 citations · Full text

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Joseph E. Pero, Michael Rossi, Hannah D. G. F. Lehman et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 36 citations · Full text

Characterization of Non-Nitrocatechol Pan and Isoform Specific Catechol-<i>O</i>-methyltransferase Inhibitors and Substrates

R. Robinson, Sean M. Smith, S. E. Wolkenberg et al. · ACS Chemical Neuroscience · 2011 · 34 citations

, , +21

[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey

Eric D. Hostetler, Sandra Sanabria Bohórquez, Hong Fan et al. · Nuclear Medicine and Biology · 2011 · 28 citations

, , +3

Rows per page

1–5 of 14